Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Oncoimmunology
|
March 8, 2014
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology
|
April 9, 2016
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination
Diana Llopiz, Fernando Aranda, Nancy Díaz-Valdés, et al.
Oncoimmunology
|
August 2, 2014
Trial watch: Immunostimulatory cytokines in cancer therapy
Erika Vacchelli, Fernando Aranda, Florine Obrist, et al.
Oncoimmunology
|
February 6, 2014
Trial Watch: Peptide vaccines in cancer therapy
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.
Oncotarget
|
January 4, 2018
Immunomodulatory effects of soluble CD5 on experimental tumor models
Inês T Simões, Fernando Aranda, Esther Carreras, et al.
Oncoimmunology
|
May 7, 2014
Trial Watch: Chemotherapy with immunogenic cell death inducers
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
International Review of Cell and Molecular Biology
|
July 1, 2022
Overcoming the limitations of cytokines to improve cancer therapy
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Oncoimmunology
|
September 18, 2018
Immune effectors responsible for the elimination of hyperploid cancer cells
Fernando Aranda, Kariman Chaba, Norma Bloy, et al.
Methods in Cell Biology
|
March 31, 2024
Peritoneal carcinomatosis in mouse models
Leire Arrizabalaga, Claudia Augusta Di Trani, Aline Risson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 22, 2025
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models
Leire Arrizabalaga, Ángela Bella, Claudia Augusta Di Trani, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Oncoimmunology
|
March 8, 2014
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology
|
April 9, 2016
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination
Diana Llopiz, Fernando Aranda, Nancy Díaz-Valdés, et al.
Oncoimmunology
|
August 2, 2014
Trial watch: Immunostimulatory cytokines in cancer therapy
Erika Vacchelli, Fernando Aranda, Florine Obrist, et al.
Oncoimmunology
|
February 6, 2014
Trial Watch: Peptide vaccines in cancer therapy
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.
Oncotarget
|
January 4, 2018
Immunomodulatory effects of soluble CD5 on experimental tumor models
Inês T Simões, Fernando Aranda, Esther Carreras, et al.
Oncoimmunology
|
May 7, 2014
Trial Watch: Chemotherapy with immunogenic cell death inducers
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
International Review of Cell and Molecular Biology
|
July 1, 2022
Overcoming the limitations of cytokines to improve cancer therapy
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Oncoimmunology
|
September 18, 2018
Immune effectors responsible for the elimination of hyperploid cancer cells
Fernando Aranda, Kariman Chaba, Norma Bloy, et al.
Methods in Cell Biology
|
March 31, 2024
Peritoneal carcinomatosis in mouse models
Leire Arrizabalaga, Claudia Augusta Di Trani, Aline Risson, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 22, 2025
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models
Leire Arrizabalaga, Ángela Bella, Claudia Augusta Di Trani, et al.
Page
of 11